GOSS
Gossamer Bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website gossamerbio.com
- Employees(FY) 178
- ISIN US38341P1021
Performance
-7.69%
1W
+17.52%
1M
-12.48%
3M
+54.87%
6M
-7.95%
YTD
-1.44%
1Y
Profile
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Technical Analysis of GOSS 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-20 23:00
- 2024-11-14 20:35
- 2024-11-13 20:35
- 2024-11-11 03:01
- 2024-11-07 05:00
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
- 2024-11-07 03:59
Gossamer Bio: Q3 Earnings Snapshot(Yahoo Finance)
- 2024-11-07 03:03
- 2024-10-30 19:00
- 2024-10-29 19:00
- 2024-10-28 19:00
- 2024-10-07 05:01
- 2024-09-24 19:00
- 2024-09-23 19:00
- 2024-08-26 04:01
- 2024-08-20 19:00
- 2024-08-19 19:00
- 2024-08-12 10:53
- 2024-08-12 05:10
Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates(Yahoo Finance)
- 2024-08-12 04:15
Gossamer Bio: Q2 Earnings Snapshot(Yahoo Finance)
- 2024-08-12 04:01
- 2024-07-24 14:35
- 2024-06-13 03:35
- 2024-06-07 04:30
- 2024-05-14 04:01
- 2024-05-10 04:30
- 2024-05-07 10:56
GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024(Investorplace)
- 2024-05-07 05:15
Gossamer Bio: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-07 04:01
- 2024-05-06 17:11
- 2024-05-06 16:31
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.